Skip to main content

Chester County Press

Grant from AstraZeneca Foundation will advance health equity in Southern Chester County

LCH Health and Community Services has been selected as a second-year grant awardee of the AstraZeneca Foundation’s Creating Health Access for Next Generation Equity (CHANGE) program, which aims to advance health equity and improve access to quality healthcare for people experiencing disadvantages due to their race, ethnicity, socioeconomic status and more. This funding will provide critical support to increase access to equitable, affordable healthcare for our community.  

This opportunity allows LCH to focus on access to behavioral health, care management for chronic health conditions, building partnerships with local schools to increase access to care for children and families, and bringing care to the community through health screenings. 

LCH serves as a safety net for families, offering vital support through connections to essential resources, including health insurance enrollment, specialist appointments, and partnerships with food and housing organizations.

“We’re grateful to the AstraZeneca Foundation for this second-year CHANGE grant and its commitment to helping us increase access to quality healthcare in our community,” said LCH CEO Ronan W. Gannon. “As we partner to advance health equity, this support will help LCH address chronic illnesses, provide preventive services, and ensure that everyone—regardless of income, language, or insurance status—can access the care they deserve.”

The AstraZeneca Foundation works to advance health equity and foster community wellbeing in the US through strategic grant-giving and capacity building support for nonprofit organizations. The Foundation also provides financial support for AstraZeneca employees affected by federally declared disasters in the US and its territories. Established in 1993 as a nonprofit charitable organization, the Foundation is a separate legal entity from AstraZeneca Pharmaceuticals with distinct legal restrictions. For more information and updates, visit www.astrazeneca-us.com/foundation.